Expression profile of human Fc receptors in mucosal tissue: Implications for antibody-dependent cellular effector functions targeting HIV-1 transmission

PLoS ONE

Volumn 11, Issue 5, 2016, Pages

  Cheeseman, Hannah M ^a   Carias, Ann M ^b   Evans, Abbey B ^a   Olejniczak, Natalia J ^a   Ziprin, Paul ^c   King, Deborah F L ^a   Hope, Thomas J ^b   Shattock, Robin J ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b NORTHWESTERN UNIVERSITY   (United States)

^c ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CD16 ANTIGEN; CD32 ANTIGEN; CD56 ANTIGEN; CD64 ANTIGEN; CD89 ANTIGEN; FC RECEPTOR; GLYCOPROTEIN P 15095; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; UNCLASSIFIED DRUG; FC(ALPHA) RECEPTOR; FCGR3B PROTEIN, HUMAN; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; LEUKOCYTE ANTIGEN;

ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ARTICLE; CLINICAL ARTICLE; COLON MUCOSA; CONTROLLED STUDY; EFFECTOR CELL; FEMALE; HEMOLYSIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN TISSUE; LAMINA PROPRIA; MALE; MONOCYTE; MYELOID DENDRITIC CELL; PENIS; PROTEIN EXPRESSION; RECTUM MUCOSA; UTERINE CERVIX; VIRUS TRANSMISSION; ADULT; ANTIBODY SPECIFICITY; BIOSYNTHESIS; BLOOD CELL; CLINICAL TRIAL (TOPIC); CYTOLOGY; DENDRITIC CELL; FEMALE GENITAL SYSTEM; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETICS; HIV INFECTIONS; HUMORAL IMMUNITY; IMMUNOLOGY; MALE GENITAL SYSTEM; MUCOSA; NATURAL KILLER CELL; RECTUM; TRANSMISSION; VIROLOGY;

ADULT; AIDS VACCINES; ANTIGENS, CD; BLOOD CELLS; CLINICAL TRIALS AS TOPIC; DENDRITIC CELLS; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENITALIA, FEMALE; GENITALIA, MALE; GPI-LINKED PROTEINS; HIV ANTIBODIES; HIV INFECTIONS; HIV-1; HUMANS; IMMUNITY, HUMORAL; KILLER CELLS, NATURAL; MALE; MONOCYTES; MUCOUS MEMBRANE; ORGAN SPECIFICITY; RECEPTORS, FC; RECEPTORS, IGG; RECTUM;

EID: 84968750570     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0154656     Document Type: Article

References (64)

1. Hladik F., McElrath M.J. Setting the stage: host invasion by HIV. Nature reviews Immunology 2008; 8 (6):447-457 Epub 2008/05/13. 10.1038/nri2302 PMID: 18469831; PubMed Central PMCID: PMCPmc2587276.
2. Rerks-Ngarm S., Pitisuttithum P., Nitayaphan S., Kaewkungwal J., Chiu J., Paris R., et al. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. The New England journal of medicine 2009; 361(23):2209-2220 Epub 2009/10/22. 10.1056/NEJMoa0908492 PMID: 19843557.
3. Haynes B.F., Gilbert P.B., McElrath M.J., Zolla-Pazner S., Tomaras G.D., Alam S.M., et al. Immune-correlates analysis of an HIV-1 vaccine efficacy trial. The New England journal of medicine 2012; 366(14):1275-1286 Epub 2012/04/06. 10.1056/NEJMoa1113425 PMID: 22475592; PubMed Central PMCID: PMCPmc3371689.
4. Tomaras G.D., Ferrari G., Shen X., Alam S.M., Liao H.X., Pollara J., et al. Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG. Proceedings of the National Academy of Sciences of the United States of America 2013; 110(22):9019-9024 Epub 2013/05/11. 10.1073/pnas.1301456110 PMID: 23661056; PubMed Central PMCID: PMCPmc3670311.
5. Yates N.L., Liao H.X., Fong Y., deCamp A, Vandergrift NA, Williams WT, et al. Vaccine-induced Env V1-V2 IgG3 correlates with lower HIV-1 infection risk and declines soon after vaccination. Science translational medicine 2014; 6(228):228ra39. Epub 2014/03/22. 10.1126/scitranslmed.3007730 PMID: 24648342; PubMed Central PMCID: PMCPmc4116665.
6. Karasavvas N., Billings E., Rao M., Williams C., Zolla-Pazner S., Bailer R.T., et al. The Thai Phase III HIV Type 1 Vaccine trial (RV144) regimen induces antibodies that target conserved regions within the V2 loop of gp120. AIDS research and human retroviruses 2012; 28(11):1444-1457 Epub 2012/10/06. 10.1089/aid.2012.0103 PMID: 23035746; PubMed Central PMCID: PMCPmc3484815.
7. Montefiori D.C., Karnasuta C., Huang Y., Ahmed H., Gilbert P., de Souza MS, et al. Magnitude and breadth of the neutralizing antibody response in the RV144 and Vax003 HIV-1 vaccine efficacy trials. The Journal of infectious diseases 2012; 206(3):431-441 Epub 2012/05/29. 10.1093/infdis/jis367 PMID: 22634875; PubMed Central PMCID: PMCPmc3392187.
8. Gottardo R., Bailer R.T., Korber B.T., Gnanakaran S., Phillips J., Shen X., et al. Plasma IgG to linear epitopes in the V2 and V3 regions of HIV-1 gp120 correlate with a reduced risk of infection in the RV144 vaccine efficacy trial. PloS one 2013; 8(9):e75665 Epub 2013/10/03. 10.1371/journal.pone.0075665 PMID: 24086607; PubMed Central PMCID: PMCPmc3784573.
9. Zolla-Pazner S., deCamp AC, Cardozo T, Karasavvas N, Gottardo R, Williams C, et al. Analysis of V2 antibody responses induced in vaccinees in the ALVAC/AIDSVAX HIV-1 vaccine efficacy trial. PloS one 2013; 8(1):e53629 Epub 2013/01/26. 10.1371/journal.pone.0053629 PMID: 23349725; PubMed Central PMCID: PMCPmc3547933.
10. Zolla-Pazner S., deCamp A, Gilbert PB, Williams C, Yates NL, Williams WT, et al. Vaccine-induced IgG antibodies to V1V2 regions of multiple HIV-1 subtypes correlate with decreased risk of HIV-1 infection. PloS one 2014; 9(2):e87572 Epub 2014/02/08. 10.1371/journal.pone.0087572 PMID: 24504509; PubMed Central PMCID: PMCPmc3913641.
11. Chung A.W., Ghebremichael M., Robinson H., Brown E., Choi I., Lane S., et al. Polyfunctional Fc-effector profiles mediated by IgG subclass selection distinguish RV144 and VAX003 vaccines. Science translational medicine 2014; 6(228):228ra38. Epub 2014/03/22. 10.1126/scitranslmed.3007736 PMID: 24648341.
12. Sobota A., Strzelecka-Kiliszek A., Gladkowska E., Yoshida K., Mrozinska K., Kwiatkowska K. Binding of IgG-opsonized particles to Fc gamma R is an active stage of phagocytosis that involves receptor clustering and phosphorylation. Journal of immunology (Baltimore, Md: 1950). 2005; 175(7):4450-4457 Epub 2005/09/24. PMID: 16177087.
13. Schmitz M., Zhao S., Schakel K., Bornhauser M., Ockert D., Rieber E.P. Native human blood dendritic cells as potent effectors in antibody-dependent cellular cytotoxicity. Blood 2002; 100(4):1502-1504 Epub 2002/08/01. PMID: 12149240.
14. Herter S., Birk M.C., Klein C., Gerdes C., Umana P., Bacac M. Glycoengineering of therapeutic antibodies enhances monocyte/macrophage-mediated phagocytosis and cytotoxicity. Journal of immunology (Baltimore, Md: 1950). 2014; 192(5):2252-2260 Epub 2014/02/04. 10.4049/jimmunol.1301249 PMID: 24489098; PubMed Central PMCID: PMCPmc3932809.
15. Teillaud J-L. Antibody-dependent Cellular Cytotoxicity (ADCC). eLS. Chichester: John Wiley & Sons, Ltd; 2012
16. Zuckerman S.H., Douglas S.D. The characterization and functional significance of plasma membrane Fc Receptors. CRC critical reviews in microbiology 1978; 7(1):1-26 Epub 1978/01/01. PMID: 383405.
17. Su B., Moog C. Which Antibody Functions are Important for an HIV Vaccine? Frontiers in immunology. 2014; 5:289 Epub 2014/07/06. 10.3389/fimmu.2014.00289 PMID: 24995008; PubMed Central PMCID: PMCPmc4062070.
18. Ackerman M.E., Dugast A.S., McAndrew E.G., Tsoukas S., Licht A.F., Irvine D.J., et al. Enhanced phagocytic activity of HIV-specific antibodies correlates with natural production of immunoglobulins with skewed affinity for FcgammaR2a and FcgammaR2b. Journal of virology 2013; 87(10):5468-5476 Epub 2013/03/08. 10.1128/jvi.03403-12 PMID: 23468489; PubMed Central PMCID: PMCPmc3648186.
19. Asmal M., Sun Y., Lane S., Yeh W., Schmidt S., Mascola J.R., et al. Antibody-Dependent Cell-Mediated Viral Inhibition Emerges after Simian Immunodeficiency Virus SIVmac251 Infection of Rhesus Monkeys Coincident with gp140-Binding Antibodies and Is Effective against Neutralization-Resistant Viruses. Journal of virology 2011; 85(11):5465-5475 10.1128/JVI.00313-11 PMID: 21450829
20. Forthal D.N., Landucci G., Chohan B., Richardson B.A., McClelland R.S., Jaoko W., et al. Antibody-dependent cell-mediated virus inhibition antibody activity does not correlate with risk of HIV-1 superinfection. Journal of acquired immune deficiency syndromes (1999). 2013; 63(1):31-33 Epub 2013/01/25. 10.1097/QAI.0b013e3182874d41 PMID: 23344546; PubMed Central PMCID: PMCPmc3625514.
21. Kramski M., Parsons M.S., Stratov I., Kent S.J. HIV-specific antibody immunity mediated through NK cells and monocytes. Current HIV research 2013; 11(5):388-406 Epub 2013/11/07. PMID: 24191935.
22. Hussain L.A., Kelly C.G., Hecht E.M., Fellowes R., Jourdan M., Lehner T. The expression of Fc receptors for immunoglobulin G in human rectal epithelium. AIDS (London, England). 1991; 5(9):1089-1094 Epub 1991/09/01. PMID: 1681818.
23. Hussain L.A., Kelly C.G., Fellowes R., Hecht E.M., Wilson J., Chapman M., et al. Expression and gene transcript of Fc receptors for IgG, HLA class II antigens and Langerhans cells in human cervico-vaginal epithelium. Clinical and experimental immunology 1992; 90(3):530-538 Epub 1992/12/01. PMID: 1360881; PubMed Central PMCID: PMCPmc1554575.
24. Hussain L.A., Lehner T. Comparative investigation of Langerhans' cells and potential receptors for HIV in oral, genitourinary and rectal epithelia. Immunology 1995; 85(3):475-484 Epub 1995/07/01. PMID: 7558138; PubMed Central PMCID: PMCPmc1383923.
25. Rogler G., Hausmann M., Vogl D., Aschenbrenner E., Andus T., Falk W., et al. Isolation and phenotypic characterization of colonic macrophages. Clinical and experimental immunology 1998; 112(2):205-215 Epub 1998/07/02. PMID: 9649182; PubMed Central PMCID: PMCPmc1904962.
26. Trifonova R.T., Lieberman J., van Baarle D. Distribution of immune cells in the human cervix and implications for HIV transmission. American journal of reproductive immunology (New York, NY: 1989). 2014; 71(3):252-264 Epub 2014/01/15. 10.1111/aji.12198 PMID: 24410939; PubMed Central PMCID: PMCPmc3943534.
27. Brandtzaeg P. Function of mucosa-associated lymphoid tissue in antibody formation. Immunological investigations 2010; 39(4-5):303-355 Epub 2010/05/11. 10.3109/08820131003680369 PMID: 20450282.
28. Mowat A.M., Agace W.W. Regional specialization within the intestinal immune system. Nature reviews Immunology 2014; 14(10):667-685 Epub 2014/09/23. 10.1038/nri3738 PMID: 25234148.
29. Smith P.D., Smythies L.E., Mosteller-Barnum M., Sibley D.A., Russell M.W., Merger M., et al. Intestinal macrophages lack CD14 and CD89 and consequently are down-regulated for LPS- and IgA-mediated activities. Journal of immunology (Baltimore, Md: 1950). 2001; 167(5):2651-2656 Epub 2001/08/18. PMID: 11509607.
30. Preza G.C., Tanner K., Elliott J., Yang O.O., Anton P.A., Ochoa M.T. Antigen-presenting cell candidates for HIV-1 transmission in human distal colonic mucosa defined by CD207 dendritic cells and CD209 macrophages. AIDS research and human retroviruses 2014; 30(3):241-249 Epub 2013/10/19. 10.1089/aid.2013.0145 PMID: 24134315; PubMed Central PMCID: PMCPmc3938918.
31. Smythies L.E., Maheshwari A., Clements R., Eckhoff D., Novak L., Vu H.L., et al. Mucosal IL-8 and TGF-beta recruit blood monocytes: evidence for cross-talk between the lamina propria stroma and myeloid cells. Journal of leukocyte biology 2006; 80(3):492-499 Epub 2006/06/24. 10.1189/jlb.1005566 PMID: 16793909.
32. Smith P.D., Smythies L.E., Shen R., Greenwell-Wild T., Gliozzi M., Wahl S.M. Intestinal macrophages and response to microbial encroachment. Mucosal immunology 2011; 4(1):31-42 Epub 2010/10/22. 10.1038/mi.2010.66 PMID: 20962772; PubMed Central PMCID: PMCPmc3821935.
33. Hsieh M.M., Everhart J.E., Byrd-Holt D.D., Tisdale J.F., Rodgers G.P. Prevalence of Neutropenia in the U. S Population: Age, Sex, Smoking Status, and Ethnic Differences. Annals of Internal Medicine 2007; 146 (7):486-492 10.7326/0003-4819-146-7-200704030-00004 PMID: 17404350
34. Rijken F., Kiekens R.C., Bruijnzeel P.L. Skin-infiltrating neutrophils following exposure to solar-simulated radiation could play an important role in photoageing of human skin. The British journal of dermatology 2005; 152(2):321-328 Epub 2005/02/25. 10.1111/j.1365-2133.2004.06335.x PMID: 15727646.
35. Givan A.L., White H.D., Stern J.E., Colby E., Gosselin E.J., Guyre P.M., et al. Flow cytometric analysis of leukocytes in the human female reproductive tract: comparison of fallopian tube, uterus, cervix, and vagina. American journal of reproductive immunology (New York, NY: 1989). 1997; 38(5):350-359 Epub 1997/11/14. PMID: 9352027.
36. Kvedaraite E., Lourda M., Idestrom M., Chen P., Olsson-Akefeldt S., Forkel M., et al. Tissue-infiltrating neutrophils represent the main source of IL-23 in the colon of patients with IBD. Gut 2015. Epub 2015/07/15. 10.1136/gutjnl-2014-309014 PMID: 26160381.
37. Shen L., Guyre P.M., Fanger M.W. Polymorphonuclear leukocyte function triggered through the high affinity Fc receptor for monomeric IgG. Journal of immunology (Baltimore, Md: 1950). 1987; 139(2):534-538 Epub 1987/07/15. PMID: 2955043.
38. Petroni K.C., Shen L., Guyre P.M. Modulation of human polymorphonuclear leukocyte IgG Fc receptors and Fc receptor-mediated functions by IFN-gamma and glucocorticoids. Journal of immunology (Baltimore, Md: 1950). 1988; 140(10):3467-3472 Epub 1988/05/15. PMID: 2966197.
39. Pudney J., Quayle A.J., Anderson D.J. Immunological microenvironments in the human vagina and cervix: mediators of cellular immunity are concentrated in the cervical transformation zone. Biology of reproduction 2005; 73(6):1253-1263 Epub 2005/08/12. 10.1095/biolreprod.105.043133 PMID: 16093359.
40. Anderson D., Politch J.A., Pudney J. HIV infection and immune defense of the penis. American journal of reproductive immunology (New York, NY: 1989). 2011; 65(3):220-229 Epub 2011/01/11. 10.1111/j.1600-0897.2010.00941.x PMID: 21214659; PubMed Central PMCID: PMCPmc3076079.
41. Nimmerjahn F., Ravetch J.V. Fcgamma receptors as regulators of immune responses. Nature reviews Immunology 2008; 8(1):34-47 Epub 2007/12/08. 10.1038/nri2206 PMID: 18064051.
42. Bakema J.E.,Van Egmond M. The human immunoglobulin A Fc receptor FcalphaRI: a multifaceted regulator of mucosal immunity. Mucosal immunology 2011; 4(6):612-624 Epub 2011/09/23. 10.1038/mi.2011.36 PMID: 21937986.
43. Bolland S., Ravetch J.V. Inhibitory pathways triggered by ITIM-containing receptors. Advances in immunology 1999; 72:149-177 Epub 1999/06/11. PMID: 10361574.
44. Moller M.J., Kammerer R., von Kleist S. A distinct distribution of natural killer cell subgroups in human tissues and blood. International journal of cancer Journal international du cancer 1998; 78(5):533-538 Epub 1998/11/10. PMID: 9808518.
45. Van de Winkel JG, Capel P.J. Human IgG Fc receptor heterogeneity: molecular aspects and clinical implications. Immunology today 1993; 14(5):215-221 Epub 1993/05/01. 10.1016/0167-5699(93)90166-i PMID: 8517920.
46. Kerst J.M., van de Winkel JG, Evans AH, de Haas M, Slaper-Cortenbach IC, de Wit TP, et al. Granulocyte colony-stimulating factor induces hFc gamma RI (CD64 antigen)-positive neutrophils via an effect on myeloid precursor cells. Blood 1993; 81(6):1457-1464 Epub 1993/03/15. PMID: 7680917.
47. Hamre R., Farstad I.N., Brandtzaeg P., Morton H.C. Expression and Modulation of the Human Immunoglobulin A Fc Receptor (CD89) and the FcR γ Chain on Myeloid Cells in Blood and Tissue.Scandinavian journal of immunology 2003; 57(6):506-516 10.1046/j.1365-3083.2003.01220.x PMID: 12791088
48. Perussia B., Dayton E.T., Lazarus R., Fanning V., Trinchieri G. Immune interferon induces the receptor for monomeric IgG1 on human monocytic and myeloid cells. The Journal of experimental medicine 1983; 158(4):1092-1113 Epub 1983/10/01. PMID: 6225822; PubMed Central PMCID: PMCPmc2187379.
49. Guyre P.M., Morganelli P.M., Miller R. Recombinant immune interferon increases immunoglobulin G Fc receptors on cultured human mononuclear phagocytes. J Clin Invest 1983; 72(1):393-397 Epub 1983/07/01. PMID: 6192145; PubMed Central PMCID: PMCPmc1129195.
50. Shen L., Collins J.E., Schoenborn M.A., Maliszewski C.R. LIPOPOLYSACCHARIDE AND CYTOKINE AUGMENTATION OF HUMAN MONOCYTE IGA RECEPTOR EXPRESSION AND FUNCTION Journal of Immunology 1994; 152(8):4080-4086 PMID: WOS:A1994NF01800040.
51. Gessl A., Willheim M., Spittler A., Agis H., Krugluger W., Boltz-Nitulescu G. Influence of Tumour Necrosis Factor-α on the Expression of Fc IgG and IgA Receptors, and Other Markers by Cultured Human Blood Monocytes and U937 Cells. Scandinavian journal of immunology 1994; 39(2):151-156 10.1111/j.1365-3083.1994.tb03354.x PMID: 8296157
52. te Velde AA, de Waal Malefijt R, Huijbens RJ, de Vries JE, Figdor CG. IL-10 stimulates monocyte Fc gamma R surface expression and cytotoxic activity. Distinct regulation of antibody-dependent cellular cytotoxicity by IFN-gamma, IL-4, and IL-10. Journal of immunology (Baltimore, Md: 1950). 1992; 149 (12):4048-52. Epub 1992/12/15. PMID: 1460289.
53. Hardy H., Harris J., Lyon E., Beal J., Foey A.D. Prebiotics, Probiotics and Immunomodulation of Gut Mucosal Defences: Homeostasis and Immunopathology. Nutrients 2013; 5(6):1869-1912 10.3390/nu5061869 PMID: PMC3725482.
54. Wu H.-J., Wu E. The role of gut microbiota in immune homeostasis and autoimmunity. Gut Microbes 2012; 3(1):4-14 10.4161/gmic.19320 PMID: PMC3337124.
55. Wira C.R., Fahey J.V., Sentman C.L., Pioli P.A., Shen L. Innate and adaptive immunity in female genital tract: cellular responses and interactions. Immunological Reviews 2005; 206(1):306-335 10.1111/j.0105-2896.2005.00287.x
56. Wira C.R., Rodriguez-Garcia M., Patel M.V. The role of sex hormones in immune protection of the female reproductive tract. Nature reviews Immunology 2015; 15(4):217-230 Epub 2015/03/07. 10.1038/nri3819 PMID: 25743222; PubMed Central PMCID: PMCPmc4716657.
57. Fischetti L., Barry S.M., Hope T.J., Shattock R.J. HIV-1 infection of human penile explant tissue and protection by candidate microbicides. AIDS (London, England). 2009; 23(3):319-328 10.1097/QAD.0b013e328321b778 PMID: PMC4349942.
58. Lemos M.P., Lama J.R., Karuna S.T., Fong Y., Montano S.M., Ganoza C., et al. The inner foreskin of healthy males at risk of HIV infection harbors epithelial CD4+ CCR5+ cells and has features of an inflamed epidermal barrier. PloS one 2014; 9(9):e108954 Epub 2014/10/01. 10.1371/journal.pone.0108954 PMID: 25268493; PubMed Central PMCID: PMCPmc4182607.
59. Prodger J.L., Gray R., Kigozi G., Nalugoda F., Galiwango R., Hirbod T., et al. Foreskin T-cell subsets differ substantially from blood with respect to HIV co-receptor expression, inflammatory profile, and memory status. Mucosal immunology 2012; 5(2):121-128 Epub 2011/11/18. 10.1038/mi.2011.56 PMID: 22089029; PubMed Central PMCID: PMCPmc3288185.
60. Prodger J.L., Hirbod T., Gray R., Kigozi G., Nalugoda F., Galiwango R., et al. HIV Infection in Uncircumcised Men Is Associated With Altered CD8 T-cell Function But Normal CD4 T-cell Numbers in the Foreskin. The Journal of infectious diseases 2014; 209(8):1185-1194 Epub 2013/11/28. 10.1093/infdis/jit644 PMID: 24277744; PubMed Central PMCID: PMCPmc3969543.
61. Hanel K.H., Cornelissen C., Luscher B., Baron J.M. Cytokines and the skin barrier. International journal of molecular sciences 2013; 14(4):6720-6745 Epub 2013/03/28. 10.3390/ijms14046720 PMID: 23531535; PubMed Central PMCID: PMCPmc3645662.
62. Teirlinck A.C., Roestenberg M., Bijker E.M., Hoffman S.L., Sauerwein R.W., Scholzen A. Plasmodium falciparum Infection of Human Volunteers Activates Monocytes and CD16+ Dendritic Cells and Induces Upregulation of CD16 and CD1c Expression. Infect Immun 2015; 83(9):3732-3739 Epub 2015/07/15. 10.1128/iai.00473-15 PMID: 26169270; PubMed Central PMCID: PMCPmc4534665.
63. Ward K.N., Warrell M.J., Rhodes J., Looareesuwan S., White N.J. Altered expression of human monocyte Fc receptors in Plasmodium falciparum malaria. Infection and Immunity 1984; 44(3):623-626 PMID: PMC263647.
64. Smalls-Mantey A., Connors M., Sattentau Q.J. Comparative efficiency of HIV-1-infected T cell killing by NK cells, monocytes and neutrophils. PloS one 2013; 8(9):e74858 Epub 2013/09/17. 10.1371/journal.pone.0074858 PMID: 24040353; PubMed Central PMCID: PMCPmc3769266.